WHO ICTRP trial
A prospective, multi-center, randomized, and controlled clinical trial to…
ChiCTR1800014787 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800014787 |
|---|---|
| Public title | A prospective, multi-center, randomized, and controlled clinical trial to evaluate the effectiveness and safety of intense pulsed light and laser system (M22) in dry eye patients caused by meibomian gland dysfunction (MGD) compared to basic physical therapy |
| Scientific title | A prospective, multi-center, randomized, and controlled clinical trial to evaluate the effectiveness and safety of intense pulsed light and laser system (M22) in dry eye patients caused by meibomian gland dysfunction (MGD) compared to basic physical therapy |
| Primary sponsor | Peking University First Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | Dry eye disease |
| Interventions | Trial:Intense pulsed light and meibomian gland massage;Control:Hot compress and meibomian gland massage |
| Registration date | Feb 5, 2018 |
| Target size | Trial:60;Control:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: